MicroTransponder Secures $65 Million to Enhance Vivistim Adoption for Chronic Stroke Recovery
AUSTIN, Texas, March 12, 2025 /PRNewswire/ — Announcing a $65 million Series F financing round, MicroTransponder®, Inc., one of the fastest-growing stroke companies, is transforming the stroke continuum of care with its FDA-approved Vivistim® Paired VNS™ System. The round was... Read More →
May Health Appoints Seasoned Medtech Executive, Colby Holtshouse, as President and CEO
Leadership transition comes as Company focuses on clinical evaluation of its novel Ovarian Rebalancing™ technology, a one-time transvaginal ablation procedure designed to restore ovulation in women with PCOS, a leading cause of infertility PARIS, March 10, 2025 /PRNewswire/ — May... Read More →
Lungpacer wins FDA IDE for AeroNova system
Lungpacer Medical announced today that it received FDA investigational device exemption (IDE) to begin a trial for its AeroNova system. The STARI (stimulation to activate respiration) trial evaluates the feasibility of the investigational AeroNova system. It looks at the system... Read More →
CLEW Announces the Launch of its Sepsis Virtual Unit to Enhance SEP-1 Compliance and Improve Patient Outcomes
BOSTON, March 10, 2025 /PRNewswire/ — CLEW, a leading provider of AI-driven clinical surveillance solutions, today announced the launch of its Sepsis Virtual Unit (SVU), designed to help healthcare organizations improve sepsis detection, enhance SEP-1 compliance, and drive better patient... Read More →
Let’s Talk About Women’s Health – ReConstruct
When promoting the ReConstruct technology, which improve the lives of patients undergoing breast reconstruction, our social media team found that the use of the world “breast” was being flagged as “inappropriate” by the algorithm of certain social media sites. Thus,... Read More →
NovaGray partners with Eurofins Biomnis to tailor cancer treatments to each patient
EXCLUSIVE – 10 years after its creation, medtech company NovaGray has signed a decisive partnership with Eurofins Biomnis to enable breast cancer patients to assess their resistance to radiotherapy. Nearly 30 years of work have come to fruition. ” We... Read More →
Accuryn Medical Achieves Sales Milestone of 100,000 Catheters Shipped Nationwide
HAYWARD, Calif., March 4, 2025 /PRNewswire/ — Accuryn Medical, a company dedicated to addressing acute kidney injury (AKI), through real-time renal monitoring and assessment based on global clinical practice guidelines, today announced that they have shipped 100,000 SmartFoley catheters across... Read More →
Backgrounder: PacifiCan announces $18.3 million to scale up local businesses, boost B.C. exports, and opens new intake for business growth program featuring HealthTech Connex
Funding will enable HealthTech Connex, a life sciences company based in Surrey, to expand its operations. The company’s advanced brain imaging medical device, NeuroCatch® Platform, evaluates cognitive function within six minutes at the point-of-care. This investment will allow HealthTech Connex... Read More →
Discure Technologies Accepted into FDA TAP Program for Its Breakthrough Device for Degenerative Disc Disease
FDA’s Total Product Life Cycle (TPLC) Advisory Program acceptance will accelerate development and market access for its bioelectronic therapy for leading cause of low back pain PETACH-TIKVA, Israel, March 04, 2025 (GLOBE NEWSWIRE) — Discure Technologies, a clinical-stage medical... Read More →
Israeli biomedical firm Nurami bags $30m
Israel-based biomedical company Nurami Medical has raised US$30 million in its latest funding round. The funds will help expand its workforce and scale operations, including the construction of a commercial manufacturing facility, research and development lab, and clean rooms for... Read More →